Trial intelligence / Profile preview

Vaginal moisturizers versus ultra-low dose estriol + Lactobacillus acidophilus vaginal tablets in pelvic organ prolapse women treated with vaginal pessary

TCTR20160621001Phase 4Recruiting

Sponsor
Mahidol University
Start
Jun 2016
Modality
Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

A Phase 4 trial of estriol, lactobacillus acidophilus in pelvic organ prolapse (POP), vaginal atrophy, vaginal dryness, sponsored by Mahidol University. Started Jun 2016; status: recruiting.

02

Drugs

estriollactobacillus acidophilus
03

Conditions

pelvic organ prolapse (POP)vaginal atrophyvaginal dryness

Beyond the preview

Go deeper on TCTR20160621001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160621001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call